Last reviewed · How we verify
NCT06760572
Airway Data Collection With the Entarik Feeding Tube System
NA trial testing Airway insertion in Healthy in 30 participants. Currently enrolling.
12 December 2025
Quick facts
| Lead sponsor | Theranova, L.L.C. |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | device feasibility |
| Enrollment | 30 |
| Start date | 13 February 2025 |
| Primary completion | 12 December 2025 |
| Estimated completion | 12 December 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Airway insertion
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
Theranova, L.L.C.
Who can join
18 and older, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate the airway detection performance of the Entarik Feeding Tube System, and to collect data when the Entarik Feeding Tube is in the Airway for device development.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06760572
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Theranova, L.L.C. trials
Trials by the same sponsor.
- NCT05948605 — EMPOWER AUD Pivotal Trial · NA · completed
- NCT05162833 — Evaluation of the TheraNova Neuromodulation System to Provide Durable Relief of Overactive Bladder Symptoms · NA · completed
- NCT04758247 — Evaluation of the TheraNova Neuromodulation System for the Treatment of Overactive Bladder Symptoms · NA · completed
- NCT04901481 — Empower Neuromodulation System - Pilot Study for Anxiety Treatment · NA · terminated
- NCT04166045 — Evaluation of Peripheral Nerve Stimulation for Acute Treatment of Migraine Pain · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06760572 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Theranova, L.L.C.
- Last refreshed: 13 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06760572.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing